 Mamuka Kvaratskhelia
Concepts (403)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 35 | 2023 | 66 | 10.510 |
Why?
| | HIV-1 | 43 | 2022 | 776 | 9.010 |
Why?
| | HIV Integrase Inhibitors | 24 | 2023 | 60 | 7.950 |
Why?
| | Virus Integration | 17 | 2022 | 71 | 3.300 |
Why?
| | Protein Multimerization | 9 | 2020 | 161 | 2.820 |
Why?
| | Intercellular Signaling Peptides and Proteins | 11 | 2021 | 369 | 2.680 |
Why?
| | Virus Replication | 10 | 2021 | 405 | 2.440 |
Why?
| | DNA, Viral | 11 | 2022 | 356 | 1.830 |
Why?
| | Virion | 7 | 2022 | 78 | 1.700 |
Why?
| | Anti-HIV Agents | 5 | 2022 | 664 | 1.700 |
Why?
| | Protein Binding | 42 | 2021 | 1975 | 1.660 |
Why?
| | RNA, Viral | 13 | 2022 | 572 | 1.630 |
Why?
| | HEK293 Cells | 22 | 2020 | 625 | 1.430 |
Why?
| | HIV Infections | 15 | 2023 | 2459 | 1.390 |
Why?
| | Capsid | 5 | 2022 | 77 | 1.340 |
Why?
| | Integrases | 6 | 2017 | 123 | 1.280 |
Why?
| | Leukemia Virus, Murine | 4 | 2016 | 16 | 1.220 |
Why?
| | Drug Resistance, Viral | 4 | 2017 | 98 | 1.190 |
Why?
| | Allosteric Regulation | 13 | 2023 | 85 | 1.140 |
Why?
| | Gene Products, gag | 4 | 2018 | 38 | 1.130 |
Why?
| | Mass Spectrometry | 15 | 2017 | 681 | 1.080 |
Why?
| | Endodeoxyribonucleases | 8 | 2001 | 60 | 1.050 |
Why?
| | Antiviral Agents | 5 | 2023 | 654 | 1.030 |
Why?
| | Human T-lymphotropic virus 1 | 7 | 2023 | 23 | 1.030 |
Why?
| | Nucleosomes | 3 | 2022 | 131 | 1.020 |
Why?
| | Pyridines | 2 | 2019 | 440 | 1.010 |
Why?
| | Acetates | 3 | 2014 | 98 | 0.990 |
Why?
| | Mutation, Missense | 3 | 2014 | 300 | 0.940 |
Why?
| | Genome, Viral | 4 | 2021 | 124 | 0.910 |
Why?
| | Models, Molecular | 22 | 2019 | 1435 | 0.870 |
Why?
| | Nuclear Proteins | 5 | 2016 | 597 | 0.870 |
Why?
| | Prions | 1 | 2022 | 36 | 0.870 |
Why?
| | Transcription Factors | 7 | 2017 | 1570 | 0.840 |
Why?
| | HIV Seropositivity | 1 | 2022 | 111 | 0.820 |
Why?
| | HIV Reverse Transcriptase | 6 | 2019 | 27 | 0.750 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 84 | 0.740 |
Why?
| | Gene Products, pol | 1 | 2017 | 6 | 0.630 |
Why?
| | Sulfolobus | 7 | 2001 | 11 | 0.630 |
Why?
| | Quinolines | 3 | 2014 | 128 | 0.610 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 7 | 2014 | 146 | 0.600 |
Why?
| | Protein Structure, Tertiary | 13 | 2016 | 823 | 0.590 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2019 | 138 | 0.570 |
Why?
| | Archaeal Proteins | 3 | 2001 | 49 | 0.570 |
Why?
| | DNA | 12 | 2014 | 1388 | 0.560 |
Why?
| | Recombination, Genetic | 6 | 2001 | 173 | 0.540 |
Why?
| | Crystallography, X-Ray | 6 | 2020 | 422 | 0.540 |
Why?
| | Recombinant Proteins | 6 | 2013 | 1308 | 0.530 |
Why?
| | Binding Sites | 14 | 2021 | 1224 | 0.510 |
Why?
| | Moloney murine leukemia virus | 1 | 2014 | 11 | 0.510 |
Why?
| | Protein Conformation | 12 | 2018 | 848 | 0.510 |
Why?
| | Amino Acid Sequence | 18 | 2019 | 2071 | 0.500 |
Why?
| | HeLa Cells | 5 | 2020 | 583 | 0.490 |
Why?
| | Transcription Initiation Site | 2 | 2014 | 42 | 0.490 |
Why?
| | Humans | 59 | 2023 | 118972 | 0.490 |
Why?
| | Viral Proteins | 5 | 2016 | 296 | 0.480 |
Why?
| | Capsid Proteins | 3 | 2022 | 70 | 0.460 |
Why?
| | Molecular Sequence Data | 18 | 2015 | 2871 | 0.460 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 224 | 0.460 |
Why?
| | Cell Cycle Proteins | 6 | 2017 | 565 | 0.460 |
Why?
| | Nucleic Acid Conformation | 9 | 2021 | 670 | 0.450 |
Why?
| | Nuclear Pore Complex Proteins | 3 | 2022 | 34 | 0.450 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 300 | 0.450 |
Why?
| | beta Karyopherins | 1 | 2012 | 8 | 0.440 |
Why?
| | Integrase Inhibitors | 1 | 2012 | 1 | 0.430 |
Why?
| | Indoles | 1 | 2014 | 316 | 0.420 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 28 | 0.410 |
Why?
| | Cell Line | 11 | 2019 | 2707 | 0.410 |
Why?
| | Avian Leukosis Virus | 2 | 2017 | 7 | 0.410 |
Why?
| | Protein Domains | 4 | 2020 | 212 | 0.400 |
Why?
| | RNA, Transfer | 2 | 2016 | 119 | 0.390 |
Why?
| | Archaea | 2 | 2001 | 70 | 0.380 |
Why?
| | Catalytic Domain | 8 | 2016 | 206 | 0.380 |
Why?
| | Nuclear Pore | 2 | 2021 | 14 | 0.370 |
Why?
| | Viral Nonstructural Proteins | 3 | 2016 | 59 | 0.350 |
Why?
| | Proteins | 4 | 2020 | 938 | 0.350 |
Why?
| | Peptides | 5 | 2018 | 879 | 0.350 |
Why?
| | Gene Products, tax | 3 | 2019 | 9 | 0.350 |
Why?
| | DNA Footprinting | 1 | 2008 | 28 | 0.340 |
Why?
| | RNA-Binding Proteins | 4 | 2018 | 371 | 0.330 |
Why?
| | DNA-Binding Proteins | 9 | 2017 | 1346 | 0.330 |
Why?
| | Structure-Activity Relationship | 5 | 2021 | 522 | 0.330 |
Why?
| | Hepacivirus | 3 | 2016 | 230 | 0.320 |
Why?
| | Histones | 3 | 2022 | 552 | 0.310 |
Why?
| | Virus Assembly | 5 | 2022 | 67 | 0.310 |
Why?
| | Salicylates | 2 | 2016 | 32 | 0.300 |
Why?
| | Cytoplasm | 2 | 2021 | 269 | 0.290 |
Why?
| | Molecular Dynamics Simulation | 2 | 2020 | 213 | 0.290 |
Why?
| | Protein Footprinting | 5 | 2011 | 9 | 0.280 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 332 | 0.280 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 25 | 0.280 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 200 | 0.280 |
Why?
| | Holliday Junction Resolvases | 8 | 2001 | 8 | 0.280 |
Why?
| | DNA Damage | 4 | 2021 | 357 | 0.270 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 40 | 0.270 |
Why?
| | Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.270 |
Why?
| | Pyridoxal Phosphate | 1 | 2004 | 21 | 0.260 |
Why?
| | Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.260 |
Why?
| | Aptamers, Nucleotide | 2 | 2018 | 74 | 0.250 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 62 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 3 | 2017 | 408 | 0.240 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 80 | 0.240 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 4 | 0.240 |
Why?
| | Lysine | 7 | 2022 | 248 | 0.230 |
Why?
| | Receptors, Virus | 2 | 2019 | 78 | 0.230 |
Why?
| | Magnesium | 3 | 2000 | 150 | 0.230 |
Why?
| | Chromatography, Gel | 4 | 2009 | 133 | 0.230 |
Why?
| | Cell Nucleus | 2 | 2021 | 580 | 0.230 |
Why?
| | Protein Structure, Quaternary | 4 | 2008 | 116 | 0.220 |
Why?
| | Mutagenesis, Site-Directed | 6 | 2009 | 363 | 0.220 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 5 | 0.220 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 101 | 0.220 |
Why?
| | Chromosomes, Human | 1 | 2022 | 41 | 0.220 |
Why?
| | Carboxylic Acids | 2 | 2019 | 30 | 0.220 |
Why?
| | Histone Code | 1 | 2022 | 29 | 0.220 |
Why?
| | Drugs, Investigational | 1 | 2022 | 31 | 0.220 |
Why?
| | Thiophenes | 2 | 2016 | 106 | 0.220 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 139 | 0.220 |
Why?
| | Oligonucleotides | 3 | 2018 | 140 | 0.210 |
Why?
| | Phenylalanine | 1 | 2022 | 66 | 0.210 |
Why?
| | Proteolysis | 3 | 2017 | 146 | 0.210 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 113 | 0.210 |
Why?
| | Protein Subunits | 2 | 2015 | 211 | 0.210 |
Why?
| | Viral Core Proteins | 2 | 2012 | 21 | 0.210 |
Why?
| | Drug Discovery | 3 | 2019 | 124 | 0.210 |
Why?
| | Glycine | 1 | 2022 | 162 | 0.210 |
Why?
| | RNA | 1 | 2008 | 833 | 0.200 |
Why?
| | HTLV-I Infections | 4 | 2019 | 21 | 0.200 |
Why?
| | Peroxidases | 2 | 1999 | 29 | 0.200 |
Why?
| | Chromatin | 2 | 2022 | 441 | 0.200 |
Why?
| | Reverse Transcription | 1 | 2021 | 19 | 0.200 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 13 | 0.200 |
Why?
| | Tea | 2 | 1997 | 10 | 0.190 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 40 | 0.190 |
Why?
| | Isoenzymes | 3 | 1999 | 297 | 0.190 |
Why?
| | Purines | 1 | 2002 | 161 | 0.190 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 30 | 0.190 |
Why?
| | Manganese | 2 | 1999 | 55 | 0.190 |
Why?
| | Cross-Linking Reagents | 2 | 2016 | 186 | 0.190 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 827 | 0.190 |
Why?
| | Necrosis | 1 | 2021 | 230 | 0.190 |
Why?
| | Neuroblastoma | 1 | 2021 | 135 | 0.180 |
Why?
| | Retroviridae Proteins | 2 | 2017 | 12 | 0.180 |
Why?
| | Base Sequence | 7 | 2016 | 2159 | 0.180 |
Why?
| | Amino Acid Substitution | 2 | 2013 | 276 | 0.180 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2011 | 81 | 0.180 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2000 | 348 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2013 | 394 | 0.180 |
Why?
| | Stereoisomerism | 1 | 2019 | 93 | 0.170 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 42 | 0.170 |
Why?
| | Amino Acids | 1 | 2022 | 464 | 0.170 |
Why?
| | Gene Products, vpr | 1 | 2018 | 1 | 0.170 |
Why?
| | Myxovirus Resistance Proteins | 1 | 2018 | 8 | 0.170 |
Why?
| | Glycerol | 1 | 2018 | 88 | 0.160 |
Why?
| | Substrate Specificity | 4 | 2016 | 371 | 0.160 |
Why?
| | Protein Folding | 2 | 2016 | 250 | 0.160 |
Why?
| | Mutation | 6 | 2023 | 3457 | 0.160 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 85 | 0.150 |
Why?
| | Peroxidase | 1 | 1997 | 170 | 0.150 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 33 | 0.150 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 50 | 0.150 |
Why?
| | 5' Untranslated Regions | 2 | 2021 | 52 | 0.150 |
Why?
| | Immunoblotting | 2 | 2016 | 307 | 0.150 |
Why?
| | meta-Aminobenzoates | 1 | 2016 | 1 | 0.150 |
Why?
| | alpha-Defensins | 1 | 2016 | 11 | 0.150 |
Why?
| | Nucleocapsid | 1 | 2016 | 17 | 0.150 |
Why?
| | Cyclophilin A | 1 | 2016 | 24 | 0.150 |
Why?
| | Adenosine | 1 | 2018 | 211 | 0.140 |
Why?
| | Protein Structure, Secondary | 3 | 2008 | 338 | 0.140 |
Why?
| | DNA Packaging | 1 | 2016 | 22 | 0.140 |
Why?
| | Ribonuclease P | 1 | 2016 | 25 | 0.140 |
Why?
| | Mutant Proteins | 2 | 2014 | 100 | 0.140 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 178 | 0.140 |
Why?
| | Dynamic Light Scattering | 1 | 2016 | 7 | 0.140 |
Why?
| | DNA, Single-Stranded | 3 | 2006 | 114 | 0.140 |
Why?
| | Nucleic Acids | 1 | 2016 | 59 | 0.140 |
Why?
| | Calcium | 2 | 2021 | 1169 | 0.140 |
Why?
| | Morphogenesis | 1 | 2016 | 167 | 0.130 |
Why?
| | Drug Design | 1 | 2016 | 160 | 0.130 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 139 | 0.130 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2005 | 372 | 0.130 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 173 | 0.130 |
Why?
| | Histidine | 1 | 2014 | 63 | 0.130 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 302 | 0.130 |
Why?
| | Models, Chemical | 1 | 2016 | 274 | 0.130 |
Why?
| | Animals | 12 | 2021 | 33381 | 0.120 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 105 | 0.120 |
Why?
| | Escherichia coli | 4 | 2007 | 758 | 0.120 |
Why?
| | Hepatitis C | 1 | 2016 | 217 | 0.120 |
Why?
| | Circular Dichroism | 2 | 2012 | 139 | 0.120 |
Why?
| | DNA Repair | 2 | 2009 | 198 | 0.120 |
Why?
| | Nucleoproteins | 2 | 2017 | 28 | 0.120 |
Why?
| | Peptide Mapping | 2 | 2007 | 63 | 0.120 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 453 | 0.120 |
Why?
| | Protein Interaction Mapping | 2 | 2012 | 104 | 0.120 |
Why?
| | Hydrolysis | 3 | 2007 | 176 | 0.110 |
Why?
| | Genetic Vectors | 1 | 2014 | 302 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 420 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2017 | 726 | 0.110 |
Why?
| | Azepines | 1 | 2013 | 74 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 136 | 0.110 |
Why?
| | Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.110 |
Why?
| | HTLV-II Infections | 1 | 2012 | 2 | 0.110 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 20 | 0.110 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2021 | 84 | 0.110 |
Why?
| | Genetic Therapy | 1 | 2014 | 267 | 0.110 |
Why?
| | Thermodynamics | 3 | 2020 | 392 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 2851 | 0.110 |
Why?
| | Calorimetry | 3 | 2001 | 59 | 0.110 |
Why?
| | Indoleacetic Acids | 1 | 2012 | 3 | 0.110 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 86 | 0.110 |
Why?
| | Triazoles | 1 | 2013 | 134 | 0.110 |
Why?
| | Potassium Permanganate | 2 | 2002 | 3 | 0.100 |
Why?
| | RNA Interference | 1 | 2013 | 460 | 0.100 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 13 | 0.100 |
Why?
| | Virology | 1 | 2010 | 20 | 0.100 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 56 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 139 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 551 | 0.090 |
Why?
| | Kinetics | 4 | 2009 | 1624 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 183 | 0.090 |
Why?
| | DNA Polymerase beta | 1 | 2009 | 5 | 0.090 |
Why?
| | Ribonuclease H | 3 | 2007 | 11 | 0.090 |
Why?
| | Cloning, Molecular | 2 | 2000 | 546 | 0.090 |
Why?
| | Furans | 1 | 2008 | 23 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 397 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 289 | 0.080 |
Why?
| | Urea | 1 | 2008 | 77 | 0.080 |
Why?
| | Conserved Sequence | 2 | 2017 | 219 | 0.080 |
Why?
| | Models, Biological | 3 | 2019 | 1715 | 0.080 |
Why?
| | Autoantigens | 1 | 2011 | 397 | 0.080 |
Why?
| | Nuclear Lamina | 1 | 2007 | 10 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 401 | 0.080 |
Why?
| | Retroviridae | 2 | 2010 | 89 | 0.080 |
Why?
| | Proteomics | 1 | 2013 | 876 | 0.080 |
Why?
| | RNA Splicing | 2 | 2015 | 243 | 0.070 |
Why?
| | RNA, Small Interfering | 2 | 2023 | 564 | 0.070 |
Why?
| | Phytic Acid | 1 | 2006 | 44 | 0.070 |
Why?
| | Ribonucleoproteins | 2 | 2020 | 88 | 0.070 |
Why?
| | Biotinylation | 1 | 2006 | 31 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 381 | 0.070 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2006 | 78 | 0.070 |
Why?
| | Electron Spin Resonance Spectroscopy | 3 | 1999 | 83 | 0.070 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 81 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1633 | 0.060 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 5 | 0.060 |
Why?
| | Viral Fusion Proteins | 1 | 2004 | 20 | 0.060 |
Why?
| | Calreticulin | 1 | 2004 | 24 | 0.060 |
Why?
| | Avian Proteins | 1 | 2004 | 20 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 50 | 0.060 |
Why?
| | Carbohydrates | 1 | 2004 | 59 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 984 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 940 | 0.060 |
Why?
| | Glycosylation | 1 | 2004 | 129 | 0.060 |
Why?
| | Dimerization | 4 | 2007 | 183 | 0.060 |
Why?
| | Chickens | 1 | 2004 | 185 | 0.060 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 13 | 0.060 |
Why?
| | Oxazines | 1 | 2023 | 25 | 0.060 |
Why?
| | Genes, Viral | 1 | 2023 | 93 | 0.060 |
Why?
| | Acetylation | 1 | 2004 | 217 | 0.060 |
Why?
| | Thymine | 1 | 2003 | 12 | 0.060 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2003 | 34 | 0.060 |
Why?
| | Retroelements | 1 | 2003 | 34 | 0.060 |
Why?
| | DNA, Fungal | 1 | 2003 | 69 | 0.060 |
Why?
| | Mice | 4 | 2013 | 15520 | 0.060 |
Why?
| | Aspartic Acid | 1 | 2022 | 86 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 982 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 15 | 0.050 |
Why?
| | Static Electricity | 1 | 2022 | 121 | 0.050 |
Why?
| | Pyrococcus | 1 | 2001 | 2 | 0.050 |
Why?
| | Methylation | 1 | 2022 | 204 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2021 | 24 | 0.050 |
Why?
| | Fluorescence Polarization | 1 | 2001 | 35 | 0.050 |
Why?
| | DNA Primers | 2 | 2000 | 533 | 0.050 |
Why?
| | Pyrococcus furiosus | 1 | 2001 | 3 | 0.050 |
Why?
| | Chromatography | 1 | 2001 | 25 | 0.050 |
Why?
| | Enzyme Stability | 2 | 1999 | 75 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2007 | 1055 | 0.050 |
Why?
| | Entropy | 1 | 2020 | 35 | 0.050 |
Why?
| | Genes, Archaeal | 1 | 2000 | 7 | 0.050 |
Why?
| | Candida albicans | 1 | 2000 | 58 | 0.050 |
Why?
| | Dogs | 1 | 2021 | 371 | 0.050 |
Why?
| | Time Factors | 2 | 2001 | 6412 | 0.050 |
Why?
| | Peptide Fragments | 1 | 2004 | 702 | 0.050 |
Why?
| | DNA, Archaeal | 1 | 2000 | 16 | 0.050 |
Why?
| | Cations, Divalent | 1 | 1999 | 52 | 0.050 |
Why?
| | Phosphoglycerate Mutase | 1 | 1999 | 1 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 121 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 495 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 3 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2000 | 336 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 12 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 874 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 11 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1158 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2018 | 15 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 607 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 576 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 41 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 459 | 0.040 |
Why?
| | Virulence | 1 | 2019 | 240 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 311 | 0.040 |
Why?
| | Ascorbate Peroxidases | 1 | 1997 | 2 | 0.040 |
Why?
| | Salicylic Acid | 1 | 1997 | 8 | 0.040 |
Why?
| | Hot Temperature | 1 | 2000 | 334 | 0.040 |
Why?
| | Transfection | 2 | 2012 | 888 | 0.040 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1997 | 76 | 0.040 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 31 | 0.040 |
Why?
| | Cricetulus | 1 | 2017 | 98 | 0.040 |
Why?
| | Point Mutation | 2 | 2009 | 228 | 0.040 |
Why?
| | CHO Cells | 1 | 2017 | 143 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 706 | 0.040 |
Why?
| | Gene Products, rex | 1 | 2017 | 1 | 0.040 |
Why?
| | Plant Proteins | 1 | 1997 | 81 | 0.040 |
Why?
| | Molecular Weight | 1 | 1997 | 343 | 0.040 |
Why?
| | Chick Embryo | 1 | 2017 | 129 | 0.040 |
Why?
| | Potyvirus | 1 | 2016 | 1 | 0.040 |
Why?
| | Simian foamy virus | 1 | 2016 | 2 | 0.040 |
Why?
| | Acyltransferases | 1 | 2017 | 53 | 0.040 |
Why?
| | beta-Defensins | 1 | 2016 | 22 | 0.040 |
Why?
| | Chemical Precipitation | 1 | 2016 | 38 | 0.040 |
Why?
| | DNA Viruses | 1 | 2016 | 10 | 0.040 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2016 | 12 | 0.040 |
Why?
| | Cell Survival | 2 | 2011 | 1047 | 0.040 |
Why?
| | Protein Unfolding | 1 | 2016 | 34 | 0.040 |
Why?
| | Molecular Motor Proteins | 1 | 2016 | 34 | 0.040 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 148 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 508 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 164 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 146 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2478 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 131 | 0.030 |
Why?
| | Arginine | 2 | 2007 | 249 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4709 | 0.030 |
Why?
| | Introns | 1 | 2015 | 234 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1178 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 119 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 171 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 828 | 0.030 |
Why?
| | Genetic Variation | 1 | 2018 | 926 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 421 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2012 | 2680 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 22 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.030 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2012 | 14 | 0.030 |
Why?
| | Rats | 1 | 2021 | 5392 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 2012 | 85 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 240 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 3003 | 0.030 |
Why?
| | Apoptosis | 1 | 2021 | 2484 | 0.030 |
Why?
| | NF-kappa B | 1 | 2015 | 670 | 0.030 |
Why?
| | Genotype | 1 | 2016 | 1882 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 33 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 755 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 46 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 134 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 94 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2010 | 201 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 149 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 776 | 0.020 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2008 | 18 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 112 | 0.020 |
Why?
| | Fibroblasts | 1 | 2012 | 842 | 0.020 |
Why?
| | Lamin Type A | 1 | 2007 | 39 | 0.020 |
Why?
| | Schiff Bases | 1 | 2006 | 7 | 0.020 |
Why?
| | Tritium | 1 | 2006 | 70 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2006 | 15 | 0.020 |
Why?
| | 5-Hydroxytryptophan | 1 | 2006 | 22 | 0.020 |
Why?
| | Solutions | 1 | 2006 | 156 | 0.020 |
Why?
| | Palmitic Acids | 1 | 2005 | 9 | 0.020 |
Why?
| | Biotin | 1 | 2005 | 24 | 0.020 |
Why?
| | Chymotrypsin | 1 | 2005 | 21 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2005 | 84 | 0.020 |
Why?
| | Replication Protein A | 1 | 2005 | 11 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 220 | 0.020 |
Why?
| | Tryptophan | 1 | 2005 | 139 | 0.020 |
Why?
| | Plasmids | 1 | 2005 | 355 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 314 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 412 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2005 | 341 | 0.010 |
Why?
| | RNA, Fungal | 1 | 2003 | 66 | 0.010 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2003 | 84 | 0.010 |
Why?
| | Fluorometry | 1 | 2001 | 20 | 0.010 |
Why?
| | Carbocyanines | 1 | 2001 | 30 | 0.010 |
Why?
| | Fluorescein | 1 | 2001 | 27 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2001 | 76 | 0.010 |
Why?
| | Cell Membrane | 1 | 2005 | 710 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 52 | 0.010 |
Why?
| | Stem Cells | 1 | 2005 | 559 | 0.010 |
Why?
| | Enzyme Reactivators | 1 | 1999 | 2 | 0.010 |
Why?
| | Phanerochaete | 1 | 1999 | 3 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 170 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1999 | 52 | 0.010 |
Why?
| | Heme | 1 | 1999 | 54 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 316 | 0.010 |
Why?
| | Vanadates | 1 | 1999 | 29 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 97 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 1999 | 162 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 226 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 567 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 536 | 0.010 |
Why?
| | Temperature | 1 | 1999 | 622 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2001 | 759 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1489 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|